Cardiovascular risk reduction: The role of antihypertensive treatment

Norman M. Kaplan

Research output: Contribution to journalArticlepeer-review

Abstract

The effects of antihypertensive drugs on mortality from stroke, coronary artery disease (CAD), and nonvascular causes have been studied in 14 trials involving more than 37,000 patients. In the treated patients, blood pressure was 5 to 6 mm Hg lower than that in placebo-treated patients, and whereas mortality from stroke was reduced by 42%, CAD mortality was reduced by only 14%. A major reason for this lack of effect on CAD mortality is apparently the adverse effects of the primary drugs used in these trials (diuretics and beta blockers) on glucose tolerance, lipid levels, and insulin resistance. The angiotensin-converting enzyme inhibitors favorably influence many CAD risk factors, and their use can be expected to reduce CAD mortality in patients treated for hypertension.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
Volume90
Issue number2 SUPPL.1
StatePublished - 1991

ASJC Scopus subject areas

  • Nursing(all)

Fingerprint Dive into the research topics of 'Cardiovascular risk reduction: The role of antihypertensive treatment'. Together they form a unique fingerprint.

Cite this